Rep. Kinzinger Thinks Trump "Gets" How To Deal With North Korea
The United States has tried to be patient with North Korea for 25 years now, but the strategy has led to a country that is just shy of developing an intercontinental ballistic missile, a Republican congressman told Cheddar.
Illinois Representative Adam Kinzinger said that after having lunch with President Donald Trump, he is confident that the U.S. is now moving in the right direction.
“When you use diplomacy against an adversary, the only way it really works is with a credible military threat behind it, ”Kinzinger said.
Trump, who’s currently on a multi-nation trip to Asia, has made his intent to denuclearize North Korea clear. According to the White House, this is one of the goals of his trip.
“President Trump will stress the United States’ commitment to the complete, verifiable, and permanent denuclearization of the Korean Peninsula and will call on all responsible nations to act now to ensure that the North Korean regime cannot threaten the world with nuclear devastation,” the White House reports.
Kinsinger maintains, however, that while Trump “gets” how to deal with North Korea and previously emphasized the importance of having a strong military threat, the president is now looking to exhaust all viable options before resorting to military action.
With this Indo-Pacific trip, Trump is sending a dual message to both North Korea and the country's allies and adversaries, Kinzinger said.
“To our friends: hey, join us in trying to make sure that North Korea does not get a nuclear weapon; it’s in all of our interests,” he said. “To our adversaries: why don’t you join us to help us ensure this as well.”
As the U.S. continues to face supply chain shortages, President Joe Biden is reassuring U.S. consumers that the supply chain is in "very strong shape" ahead of the all-important holiday season. As supply bottlenecks start to show signs of improvement, the industry may be faced with yet another challenge: the Omicron variant. Rob Caucci, Co-Founder & Co-CEO of Fillogic joined Cheddar's Opening Bell to discuss.
Markets rebounded Monday morning after Friday's deep sell-off that saw the Dow suffer its worse day since 2020. It comes as investors continue to react to the impact of the omicron variant on the broader reopening. Eddie Ghabour, Co-Owner at the Key Advisors Group joined Cheddar's Opening Bell to discuss.
Markets bounced back this morning with travel leading the gains after plunging on Monday as the first case of Omicron was detected in the U.S. Jimmy Lee, CEO, Wealth Consulting Group joined Cheddar's Opening Bell to discuss.
The market saw investors react to comments by the World Health Organization's chief scientist, who suggested existing vaccines are likely to offer protection against the new variant. According to Thomas Hayes, chairman of Great Hill Capital, the next two weeks will be crucial as the markets watch for not only the effects of the Omicron variant, but also the Fed's decision on a taper.
It's Friday at long last. Jill and Carlo cover the latest on Omicron, including a possible superspreader event in NYC. Plus, previewing the November jobs report, a new Zoom feature no one asked for, and when it's no longer a good idea to eat Thanksgiving leftovers.
Following the Mississippi abortion case, the fate of Roe V. Wade is at stake. A decision is expected next summer, right around the time midterm candidates will be making their cases to voters. Laura Packard, executive director of Health Care Voter, joins Cheddar News to discuss how the ruling will impact upcoming elections.
Stock markets around the world continue to be impacted by fears of the new Omicron COVID-19 variant. President Biden today reiterated his stance that the new strain is cause for concern, but not cause for panic. Wells Fargo Investment Institute Global Equity Strategist Scott Wren joined Cheddar News' Closing Bell to discuss.
Jill and Carlo discuss what appears to be the beginning of the end of Roe v. Wade, another victim dies following the school shooting in Michigan, Omicron in the U.S., Trump's Covid chronology and more.
